感染科会诊对非HIV隐球菌感染患者死亡率的影响
该回顾性队列纳入147例非HIV隐球菌感染患者,比较接受与未接受感染科会诊者的90天死亡率。会诊组90天死亡率27%,未会诊组45%(P<0.001),未接受会诊的校正风险比为4.1(95%CI:2.2,7.6)。会诊组更常按指征行腰椎穿刺、使用两性霉素B和氟胞嘧啶,且疗程更长。
要点
- 感染科会诊与非HIV隐球菌患者90天死亡率降低独立相关。
- 会诊组更常按指征行腰穿、用两性霉素B和氟胞嘧啶,疗程更长。
- 建议将感染科会诊作为隐球菌感染临床诊疗的组成部分。
核心结论
- 接受感染科会诊的非HIV隐球菌患者90天内死亡风险显著更低。
- 感染科医生参与管理更符合随机对照试验和IDSA指南建立的循证实践。
研究设计与样本
- 回顾性队列研究,纳入147例连续的非HIV隐球菌感染患者,排除诊断后24小时内死亡者。
- 采用Cox回归进行生存分析,生存时间截尾于90天。
主要发现
- 会诊组真菌负荷更高,但90天死亡率低于未会诊组(27% vs 45%,P<0.001)。
- 未接受感染科会诊的校正风险比为4.1(95%CI:2.2,7.6)。
- 会诊组更常按指征行腰椎穿刺(86% vs 32%,P<0.001)。
- 会诊组更常按指征使用两性霉素B(87% vs 24%,P<0.001)和氟胞嘧啶(57% vs 16%,P<0.001)。
- 会诊组两性霉素B疗程(14 vs 11天,P=0.05)和氟胞嘧啶疗程(7.5 vs 1天,P<0.001)更长。
关键数值与推荐
- 会诊组90天死亡率27%,未会诊组45%(P<0.001)。
- 未接受感染科会诊的校正风险比4.1(95%CI:2.2,7.6)。
- 按指征行腰椎穿刺比例:会诊组86% vs 未会诊组32%(P<0.001)。
- 按指征使用两性霉素B比例:会诊组87% vs 未会诊组24%(P<0.001);氟胞嘧啶比例:57% vs 16%(P<0.001)。
临床怎么用
- 对非HIV隐球菌感染患者,建议纳入感染科会诊以改善循证治疗的实施。
- 感染科会诊应促进按指征行腰椎穿刺及规范使用两性霉素B和氟胞嘧啶。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An infectious disease (ID) consultation is often obtained to treat patients with cryptococcosis due to the complex nature of the disease, but has never been demonstrated to impact outcomes. METHODS: We assembled a retrospective cohort of 147 consecutive cases of cryptococcosis in patients without HIV. Patients who were diagnosed less than 24 hours prior to death were excluded. Survival analysis was performed with Cox regression with survival censored past 90 days. RESULTS: The patients with an ID consult had a higher fungal burden but a lower 90-day mortality compared to patients without ID involvement (27% vs 45%, p<0.001), with an adjusted hazard ratio of not receiving an ID consult of 4.1 (95% CI: 2.2, 7.6). The ID consult group was more likely to receive an indicated lumbar puncture (86% vs 32%, p<0.001), and more likely to be treated with amphotericin B (AmB) (87% vs 24%, p<0.001) and flucytosine (5-FC) (57% vs 16%, p<0.001) when indicated. The duration of therapy with AmB (14 vs 11 days, p=0.05) and 5-FC (7.5 vs 1 days, p<0.001) was longer in the ID consult group. CONCLUSIONS: Patients that received an ID consult were significantly less likely to die in the 90 days following diagnosis. Patients seen by ID physicians were more likely to be managed according to evidence based practice established by randomized controlled trials and published in IDSA guidelines. These data suggest that an ID consult should be an integral part of clinical care of patients with cryptococcosis.
引用
- Spec A, Olsen MA, Raval K, et al. Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV. Clin Infect Dis. 2016. PMID: 27927865. doi:10.1093/cid/ciw786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。